Perhaps, the observed beneficial effects of blocking Kv1.3 channels in a plethora of neurological disease models may be explained in part by the interaction between Kv1.3 channels and immune signaling proteins that coassemble in activated microglia. The gene discussed is KCNA3; the disease is nervous system disorder.